Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Energy

Daily Deal Round Up: June 22, 2022

Illumina and Celgene could exit genome researcher Human Longevity in a reverse merger while Openly raised $75m from investors including Advance Venture Partners and Gradient Ventures.


Jun 22, 2022

Here's what a typical CVC unit looks like

Asian, fintech-focused and less than seven years old – some of the CVC trends we saw when compiling the Global Corporate Venturing Directory.

Jun 22, 2022

Daily Deal Round Up: June 15, 2022

GV took part in food delivery service Wonder Group’s $350m series B round while two Hanwha subsidiaries contributed to a $145m round for eVTOL aircraft developer Overair.

Jun 15, 2022

CVC case study: Prologis Ventures' lean team

The 10-person team at Prologis Ventures is on the smaller end of the scale but has made 37 investments over the past six years.

Jun 15, 2022

CVC case study: Saint-Gobain NOVA is organised by geography

Each team member will do every part of the process, from scouting, selection to presenting ideas to the business units.

Jun 15, 2022

CVC case study: How TDK Ventures' young team grew

TDK Ventures started with a minimal team size while it was proving itself and grew it when the portfolio needed more support.

Jun 15, 2022

CVC case study: Capita Scaling Partner's equity-for-services model

Capita Scaling Partner's equity-for-services model needs a team of 28, most focusing on finding synergies between the parent and the startup.

Jun 15, 2022

What is the ideal size for a CVC team?

The short answer is: “It depends” (on strategy, focus and structure). A quick rule of thumb is 3 people per $100m in the fund.

Jun 15, 2022

Deeptech Labs unveils six for spring cohort

The Arm-backed accelerator picked six companies for its largest cohort yet, focusing on hardware, manufacturing and knowledge.

Jun 14, 2022

Daily Deal Round Up: June 9, 2022

GV participated in tech apprenticeship platform Multiverse’s $220m series D round while Amgen, UCB, UPMC and Takeda helped genetics disease drug developer Code Biotherapeutics raise $75m.

Jun 9, 2022

Australian investors in 'significant pullback'

GCV has spoken to several corporate and VC investors about the recent hit to Australia's startup scene following a post-lockdown deal surge.

Jun 9, 2022

Severstal to terminate its corporate venturing unit

The Russia-based steelmaker’s Severstal Ventures unit is shutting down amid geopolitical crisis-induced sanctions.

Jun 9, 2022
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here